Bausch + Lomb Corporation (TSX:BLCO)
Canada
· Delayed Price · Currency is CAD 22.69
-0.85 (-3.61%)
At close: Dec 5, 2025
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| U.S. and Puerto Rico Revenue | - | 2.41B |
Log In |
Log In |
Log In | Upgrade
|
| Total International Revenue | - | 2.38B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 4.93B | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.93B | 4.79B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Vision Care Revenue | 2.87B | 2.74B |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue | 876.00M | 843.00M |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue | 1.23B | 1.21B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -49.15M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.93B | 4.79B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Pharmaceuticals Revenue | 1.03B | 969.00M |
Log In |
Log In |
Log In | Upgrade
|
| Devices Revenue | 1.88B | 1.80B |
Log In |
Log In |
Log In | Upgrade
|
| OTC Revenue | 1.81B | 1.72B |
Log In |
Log In |
Log In | Upgrade
|
| Branded and Other Generics Revenue | 240.00M | 281.00M |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Revenue | 4.96B | 4.77B |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Revenue | 19.00M | 17.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 4.93B | 4.79B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2019 - 2020 |
| Vision Care Segment Profit | 839.00M | 808.00M |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Profit | 19.00M | 44.00M |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Segment Profit | 180.00M | 256.00M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Segment Profit | -652.00M | -614.00M |
Log In |
Log In |
Log In | Upgrade
|
| Amortization of Intangible Assets | -270.00M | -288.00M |
Log In |
Log In |
Log In | Upgrade
|
| Net Other Expense | -28.00M | -44.00M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -15.56M | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 72.44M | 162.00M |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2019 |
| Vision Care Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Segment Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2019 |
| Vision Care Revenue Change in Constant Currency | 10.00% |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Change in Constant Currency | 11.00% |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Change in Constant Currency | 45.00% |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Change in Constant Currency | 17.00% |
Log In |
Log In |
Log In | Upgrade
|
| Vision Care Revenue Organic Change | - |
Log In |
Log In |
Log In | Upgrade
|
| Ophthalmic Pharmaceuticals Revenue Organic Change | - |
Log In |
Log In |
Log In | Upgrade
|
| Surgical Revenue Organic Change | - |
Log In |
Log In |
Log In | Upgrade
|
| Total Revenue Organic Change | - |
Log In |
Log In |
Log In | Upgrade
|